Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

Clinical trial NCT02909452 · COMPLETED

Trial details

NCT number: NCT02909452
Sponsor: Syndax Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Bronchial Neoplasms Lung Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Digestive System Neoplasms Endocrine Gland Neoplasms Carcinoma, Non-Small-Cell Lung Lung Diseases Breast Diseases

Start date: 2016-09-20
Primary completion: 2019-07-17
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.